Invivyd宣布启动Declaration临床试验,这是针对Vyd2311的第三阶段安慰剂对照关键研究,一种用于预防Covid的疫苗替代抗体
Invivyd宣布启动Declaration临床试验,这是针对Vyd2311的第三阶段安慰剂对照关键研究,一种用于预防Covid的疫苗替代抗体
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.